NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Bronstein, Gewirtz
& Grossman, LLC notifies investors that a securities class
action has been filed in the United States District Court for the
District of New Jersey on behalf
of those who purchased shares of Enzymotec Ltd. ("Enzymotec" or the
"Company") (NasdaqGS: ENZY), during the period traceable to the
Company's Initial Public Offering (IPO) on or about
September 27, 2013 or on the open
market between September 27, 2013 and
August 4, 2014, inclusive (the "Class
Period").
The complaint charges Enzymotec and certain of its executives
with violations of federal securities laws. Specifically, the
complaint alleges that: (a) Enzymotec's Chinese business was
subject to material and readily identifiable compliance regulations
from the Chinese government; (b) Enzymotec's baby formula business
in China was jeopardized and
subject to increased volatility and decreased revenues; and (c)
Enzymotec's joint venture with AarhusKarlshamn AB, which marketed
the popular InFat product, was crumbling and subjected the Company
to liability and decreased revenues.
Plaintiff seeks to recover damages on behalf of all shareholders
who purchased shares of Enzymotec during the Class Period described
above.
No Class has yet been certified in the above action. If you wish
to review a copy of the Complaint, to discuss this action, or have
any questions, please contact Peretz
Bronstein, Esq. or his Investor Relations Coordinator
Eitan Kimelman of Bronstein, Gewirtz
& Grossman, LLC at 212-697-6484 or via email info@bgandg.com.
Those who inquire by e-mail are encouraged to include their mailing
address and telephone number. November
4, 2014 is the deadline for investors to seek a lead
plaintiff appointment. Your ability to share in any recovery
doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com
SOURCE Bronstein, Gewirtz & Grossman, LLC